Thursday, Apr 10 2025 | Time 06:11 Hrs(IST)
Business EconomyPosted at: Apr 4 2025 2:09AM


India secures US tariff exemption for pharma products: Hetero chairman

Hyderabad, Apr 3 (UNI) Dr Bandi Parthasaradhi Reddy, member of Rajya Sabha and Chairman of Hetero Group of Companies, on Thursday expressed his heartfelt gratitude to Prime Minister Narendra Modi and the Government of India for successfully securing an exemption for Indian pharmaceutical products from the US reciprocal tariff.
In a letter addressed to the Prime Minister, Dr Parthasaradhi lauded the government’s swift action and
diplomatic negotiations that led to this significant achievement.

He highlighted the crucial role this exemption will play in strengthening India’s pharmaceutical industry, boosting exports, and reinforcing India's global reputation as the "Pharmacy of the World."
“This decision is a testament to Prime Minister Modi’s leadership and diplomatic efforts in resolving trade concerns amicably," he said it will not only enhance India’s position as a reliable and quality supplier of pharmaceutical products but also improve the affordability and availability of lifesaving medicines for US patients.
The exemption is expected to have a far-reaching impact on India's economy and employment opportunities, as it ensures continued growth for the pharmaceutical sector.
Dr Parthasaradhi also acknowledged the relentless efforts of the government’s economic diplomacy and strategic engagement with the US, which played a pivotal role in achieving this favourable outcome.
“I congratulate the Prime Minister on this remarkable success and deeply appreciate the government’s
unwavering commitment to promoting India’s interests on the global stage. This exemption safeguards our pharmaceutical industry from potential trade barriers and fosters stronger international trade relations,” he added.
Dr Parthasaradhi reaffirmed his support for the Indian pharmaceutical industry and expressed optimism about continued government backing in ensuring the sector’s sustained growth and global competitiveness.
UNI KNR SS
Please log in to get detailed story.
Tags: #India secures US tariff exemption for pharma products: Hetero chairman
More News

Coromandel Intl and Ma'aden sign MoU to partner for phosphatic fertilisers

09 Apr 2025 | 7:09 PM

Hyderabad, Apr 9 (UNI) Coromandel International Limited, India’s leading agri-solutions provider, and Ma’aden, one of the world’s largest producers of phosphate fertilisers, have further strengthened their longstanding partnership by signing a Memorandum of Understanding (MoU) for the long-term supply of Di-Ammonium Phosphate (DAP) and NP/NPK fertilisers.

see more..

Signify opens 320th Philips Smart Light Hub in India, targets 500 stores in 2-3 years

09 Apr 2025 | 6:51 PM

Hyderabad, Apr 9 (UNI) Signify, the global lighting major and owner of the Philips brand, inaugurated its 320th Philips Smart Light Hub in India and the fifth in Hyderabad at Nagole on Wednesday.

see more..

09 Apr 2025 | 6:37 PM

Pankaj Kalra, CEO, Essar Oil and Gas Exploration and Production Limited, said “We welcome the RBI’s decision to cut the repo rate and adopt an accommodative stance. As global uncertainties rise, a supportive domestic environment becomes critical. Lower borrowing costs will enable us to maintain momentum in capital deployment as we continue investing in cleaner, more efficient solutions across the energy value chain.”
The strong outlook for rural demand, infrastructure investment, and services exports further reinforces the resilience of India’s energy demand, he said.

see more..

Radisson Hotel Group crosses 200-mark in South Asia

09 Apr 2025 | 6:34 PM

New Delhi, Apr 9 (UNI) In line with its ambitious growth plan for 2025, Radisson Hotel Group on Wednesday said it has signed five new hotels taking the total number crossing the 200-mark,k reflecting the Group’s strategic expansion across high growth markets and cements its position as one of India's largest international hotel operators.

see more..

RBI imposes monetary penalty on Authorised Dealer Bank – Citibank N A

09 Apr 2025 | 6:03 PM

Mumbai, Apr 9 (UNI) The Reserve Bank of India has imposed a monetary penalty of Rs 3.20 on private lender Citibank N.A. in exercise of powers vested in the Reserve Bank for not undertaking due diligence while processing the inward remittances from a Foreign Currency Account opened by a constituent, resulting in contravention of FEMA, 1999.

see more..